Buckeyes

I expect Don will say that the meeting with the FDA went well but won’t say anything more.

The FDA can approve anything it wants to for any indication. However, when a primary endpoint is missed, true scientists say that the other endpoints are exploratory.

So, my best guess is that this drug will not be approved by the FDA yet. I’d love to be wrong but doubt I am.

That being said, the safety, impressive Forest Plot, patents, drug library, lead in epigenetics should have Big Pharma ready to act. Big Pharma tends to listen to the researchers. If Kausik Ray says it has huge potential then they would believe it does as well.

I’ve been around here awhile and I don’t recall any top researchers use terms like “huge potential” and “proof of concept” with respect to RVX. If anything, we’ve been slammed at past conferences.

bfw